To explore how Medicare Advantage plans are incorporating caregiver support as a supplemental benefit and what this means for the future of care delivery, the Hopkins Business of Health Initiative convened a panel discussion bringing together three critical perspectives: payers, providers, and community-based organizations.

To explore practical pathways for implementing primary care transformation, the Hopkins Business of Health Initiative convened an expert panel featuring leaders who bridge research, policy, and practice. Rather than revisiting what is broken, this discussion focused on what it would take to realize a new primary care vision, and who is positioned to lead it.

When a Fortune 50 employer discovered it was paying 30% more for the same hospital services than its competitors, it underscored what this panel of national experts on healthcare price transparency emphasized: despite federal transparency rules, the U.S. commercial healthcare market remains a black box.

As artificial intelligence rapidly advances across healthcare, a provocative question emerges: what happens when AI systems not only match but exceed human performance in medical diagnosis, treatment planning, and even empathy? While the future of artificial superintelligence (ASI) remains speculative, the trajectory of current AI development demands serious consideration of how healthcare systems should prepare for potentially transformative technological capabilities.

Cancer represents one of the most complex challenges in medicine. Within the umbrella of cancer are manifold diseases of abnormal growth, each with different causes, molecular mechanisms, and treatment approaches. Given the inherent complexity of addressing these many types of cancer, where does cancer detection, prevention, and treatment go from here?

The American healthcare system, an intricate web of providers, insurers, patients, and employers, has failed to improve meaningfully, despite decades of medical discovery and technological advancement, but has also become increasingly expensive. Why?

Learning health systems can make the experience of health care more patient-centered while also advancing research and solving the problems faced by healthcare delivery leaders. They do this by bringing the tools and rigors of research to the delivery space and incorporating patient insights into the process. In theory, that should make academic health systems uniquely positioned to incorporate learning into operations, but in practice, it’s often a different story.

How is it possible that tobacco products are still responsible for more than 7 million deaths each year despite decades of regulatory efforts and public health messaging against their use?

With more than half of Medicare beneficiaries enrolled in MA plans, the industry faces opportunities and challenges in truly meeting the needs of underserved communities while maintaining transparency and accountability in benefit delivery. Can the MA market increase health equity for seniors, or could it exacerbate existing disparities?

Declining trust in America's health system operates on a number of different levels and the drivers of mistrust are as varied as the solutions.

In recent years, a slew of models have been developed and tested for providing care in the home: home and community-based services, long-term services and supports, palliative care, hospital-at-home care, skilled nursing facility care, and even emergency department care at home. However, the challenge of creating an integrated spectrum of care that is centered around the patient in their own home remains unsolved.

The climate crisis is not just an environmental issue—it's a health issue. With the healthcare sector responsible for 8.5 percent of the United States' greenhouse gas emissions, the industry finds itself in a paradoxical position: while working to heal and protect human health, it simultaneously contributes to a global threat that undermines these same efforts.

These treatments so far carry steep prices, and as a result, the individuals who might benefit most from their use may have the hardest time accessing them. Since most Americans receive their health insurance coverage from their employers, what do business leaders need to know about GLP-1s right now?

The application of psychedelic therapy for a range of mental and physical health issues is emerging as a transformative treatment method but federal policy has not kept pace with the industry’s rapid development.

As state and federal policy take aim at their anticompetitive effects on worker mobility and wages, how might changes in the use of noncompete agreements hinder or improve the delivery of healthcare?

The COVID-19 pandemic reminded us that the intertwined factors of race, class, geography, education, and income mean that responsibility for the health of Americans cannot and should not sit primarily with individuals or even within the domains of health care or public health.  

A public conversation around generative artificial intelligence (AI) in medicine is both long overdue and increasingly urgent. In health care applications, the stakes are heightened because of the intricate privacy considerations and the critical nature of decision-making. The potential positive impact is also enormous.